Shanghai To Check International Certification Of Domestic Drugs
This article was originally published in PharmAsia News
Shanghai’s drug procurement center will launch investigations into domestic drugs with overseas certification, including those certified by FDA, EU cGMP, Japanese JGMP and the Hong Kong Hospital Authority, reportedly paving the way for volume-driven procurements.
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.